Janus Henderson Group plc 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-14 12:11 pm Purchase | 2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | JANUS HENDERSON GROUP PLC JHG | 4,581,642 9.500% | 101,358![]() (+2.26%) | Filing |
2024-11-14 12:55 pm Sale | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | JANUS HENDERSON GROUP PLC JHG | 4,480,284 9.400% | -508,463![]() (-10.19%) | Filing |
2024-07-10 1:12 pm Purchase | 2024-06-28 | 13G | Mirum Pharmaceuticals, Inc. MIRM | JANUS HENDERSON GROUP PLC JHG | 4,988,747 10.600% | 4,988,747![]() (New Position) | Filing |